| Literature DB >> 20021696 |
Claudia Altamura1, Matthias Reinhard, Magnus-Sebastian Vry, Christoph P Kaller, Farsin Hamzei, Fabrizio Vernieri, Paolo Maria Rossini, Andreas Hetzel, Cornelius Weiller, Dorothee Saur.
Abstract
BACKGROUND: By mapping the dynamics of brain reorganization, functional magnetic resonance imaging MRI (fMRI) has allowed for significant progress in understanding cerebral plasticity phenomena after a stroke. However, cerebro-vascular diseases can affect blood oxygen level dependent (BOLD) signal. Cerebral autoregulation is a primary function of cerebral hemodynamics, which allows to maintain a relatively constant blood flow despite changes in arterial blood pressure and perfusion pressure. Cerebral autoregulation is reported to become less effective in the early phases post-stroke. This study investigated whether any impairment of cerebral hemodynamics that occurs during the acute and the subacute phases of ischemic stroke is related to changes in BOLD response. We enrolled six aphasic patients affected by acute stroke. All patients underwent a Transcranial Doppler to assess cerebral autoregulation (Mx index) and fMRI to evaluate the amplitude and the peak latency (time to peak-TTP) of BOLD response in the acute (i.e., within four days of stroke occurrence) and the subacute (i.e., between five and twelve days after stroke onset) stroke phases.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20021696 PMCID: PMC2805667 DOI: 10.1186/1471-2202-10-151
Source DB: PubMed Journal: BMC Neurosci ISSN: 1471-2202 Impact factor: 3.288
Patients' clinical characteristics.
| Pt | Age | AH | Clinical | NIHSS | Lesion site | Stenosis ICA (%) | Vessel | Trombolysis | Risk factors | |
|---|---|---|---|---|---|---|---|---|---|---|
| AH | UH | |||||||||
| 1, ♂ | 66 | L | Aphasia | 8 | PC | 0 | 0 | MCA-branch | Y | Hypert, smoke |
| 2, ♂ | 69 | L | Aphasia/Hemiparesis FB | 14 | FC, PC | 0 | 0 | MCA-branch | Y | AF |
| 3, ♂ | 63 | L | Aphasia | 6 | FC, PC | 0 | 0 | MCA-branch | Y | Hypert, AF |
| 4, ♂ | 46 | L | Aphasia | 6 | PC | 100 | 0 | M2 | N | Hypert, smoke |
| 5, ♀ | 72 | L | Aphasia | 3 | TC | 0 | 0 | MCA-branch | Y | Hypert, Chol |
| 6, ♀ | 44 | L | Aphasia | 7 | FC | 0 | 0 | MCA-branch | Y | Hypert |
Pt:patient; ♂: man, ♀: woman; AH: affected hemisphere, UH: unaffected hemisphere; L = left, R = right; Clinical Symptoms: FBC = facial/brachial/crural; NIHSS Exp 0: NIH stroke scale at emergency room admission; Lesion site: BG = basal ganglia, IC = internal capsula, PC = parietal cortex, FC = frontal cortex, TC = Temporal Cortex; Stenosis ICA = internal carotid artery; Vessel Occlusion: MCA = Middle Cerebral Artery, M2 = M2 segment of middle cerebral artery, Trombolysis: Y = yes, N = no; Risk factors: hypert = Hypertension, AF = atrial fibrillation, Smoke = cigarette smoking, Chol = hypercholesterolemia.
Figure 1Ischemic Lesions. Axial Diffusion Weighted MR images of enrolled patients. The left side of the figure corresponds to the left side of the brain.
fMRI and Cerebral hemodynamics parameters from the acute to the subacute phase of stroke
| Pt | Ex 1 | Ex 2 | NIHSS | AH | UH | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TTP | Ampl | CBFV | Mx index | TTP | Ampl | CBFV | Mx index | ||||||||||||||
| Ex 1 | Ex 2 | Ex 1 | Ex 2 | Ex 1 | Ex 2 | Ex 1 | Ex 2 | Ex 1 | Ex 2 | Ex 1 | Ex 2 | Ex 1 | Ex 2 | Ex 1 | Ex 2 | Ex 1 | Ex 2 | ||||
| 1 | 1 | 5 | 6 | 3 | 5.48 | 6.57 | 0.86 | 0.56 | 48.6 | 56.9 | 0.01 | 0.54 | 5.48 | 6.57 | 0.89 | 0.50 | 50.1 | 45.9 | -0.15 | 0.52 | |
| 2 | 2 | 8 | 14 | 13 | 5.48 | 6.57 | 0.56 | 0.42 | 39.5 | 33.1 | 0.04 | 0.41 | 5.48 | 6.57 | 0.58 | 0.48 | 43.2 | 27.1 | -0.05 | 0.28 | |
| 3 | 2 | 5 | 4 | 2 | 5.48 | 7.67 | 0.62 | 0.52 | 41.8 | 30.6 | -0.12 | 0.42 | 5.48 | 6.57 | 0.89 | 0.49 | 47.7 | 35.8 | -0.10 | 0.36 | |
| 4 | 3 | 10 | 5 | 4 | - | - | - | - | 50.3 | 53.8 | 0.14 | 0.27 | 5.52 | 5.52 | 0.25 | 0.33 | 51.4 | 43.7 | 0.42 | 0.09 | |
| 5 | 4 | 12 | 3 | 1 | 5.52 | 6.44 | 0.45 | 0.17 | 57.8 | 46.2 | 0.26 | 0.25 | 5.52 | 5.52 | 0.19 | 0.32 | 36.1 | 45.6 | 0.12 | 0.23 | |
| 6 | 1 | 9 | 3 | 3 | 5.52 | 6.44 | 0.53 | 0.34 | 62.7 | 53.1 | 0.14 | 0.66 | 5.52 | 6.44 | 0.44 | 0.53 | 77.9 | 55.4 | 0.21 | 0.57 | |
| Mean | 2.2 (1.2) | 8.2 (2.8) | 5.8 (4.2) | 4.3 (4.4) | 5.50 (0.02) | 6.74 (0.53) | 0.60 (0.16) | 0.40 (0.16) | 50.12 (8.96) | 45.62 (11.25) | 0.08 (0.13) | 0.43 (0.16) | 5.50 (0.02) | 6.20 (0.53) | 0.54 (0.30) | 0.44 (0.09) | 51.07 (14.27) | 42.25 (9.70) | 0.08 (0.22) | 0.34 (0.18) | |
| p = 0.06 | p = 0.17 | p = 0.059 | p = 0.46 | p = 0.11 | p = 0.09 | ||||||||||||||||
Parad 1 and 2: Language paradigm 1 and 2 respectively; Ex 1 and Ex 2: days from stroke onset; NIHSS NIH stroke scale at the first examination time (Ex 1) and at the second examination time (Ex 2); TTP: time to peak expressed in seconds and Ampl: Peak Amplitude of BOLD.; AH: affected hemisphere, UH: unaffected hemisphere; CBFV: mean MCA cerebral blood flow velocity expressed in cm/s; Mx index: correlation coefficient between CBFV and arterial blood pressure; Mean (SD): mean values (Standard deviation); in the bottom raw p values for comparison of each measure from Ex 1 to Ex 2 are reported, and evidenced in bold in case of statistical significance.
Parameters of Hemodynamic Response Function of BOLD signal in controls
| TTP | Ampl | TTP | Ampl | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sb | Age | R | L | R | L | Sb | Age | R | L | R | L | ||
| 1 | 60 | 5.48 | 5.48 | 0.72 | 0.52 | 7 | 66 | 5.52 | 5.52 | 0.31 | 0.28 | ||
| 2 | 69 | 5.48 | 5.48 | 0.62 | 0.58 | 8 | 45 | 5.52 | 5.52 | 0.31 | 0.42 | ||
| 3 | 71 | 5.48 | 5.48 | 0.57 | 0.85 | 9 | 59 | 5.52 | 5.52 | 0.49 | 0.41 | ||
| 4 | 56 | 5.48 | 5.48 | 0.59 | 0.68 | 10 | 41 | 5.52 | 5.52 | 0.44 | 0.49 | ||
| 5 | 58 | 5.48 | 5.48 | 0.88 | 0.93 | 11 | 57 | 6.44 | 6.44 | 0.50 | 0.67 | ||
| 6 | 46 | 5.48 | 5.48 | 0.24 | 0.22 | 12 | 52 | 5.52 | 5.52 | 0.31 | 0.37 | ||
| Mean | 60 | 5.48 | 5.48 | 0.60 | 0.63 | 53 | 5.67 | 5.67 | 0.39 | 0.44 | |||
Paradigm 1 and 2: Language paradigm 1 and 2 respectively; TTP: time to peak expressed in seconds and Ampl: Peak Amplitude of BOLD; R: right hemisphere; L: left hemisphere. Please note that differences in the mean amplitude values between table 3 and figures 2 and 3 are due to the fact, that in the table values were extracted from individual peak voxels, while in the figures they were extracted from the group peak voxel.
Figure 2BOLD signal in controls and patient 2 performing language paradigm 1. (A) HRF extracted from the peak voxel in the bilateral auditory cortex of six healthy control subjects performing language paradigm 1. Plots represent the mean contrast estimate across subjects (y-axis) within each time bin (x-axis). The dark grey bar indicates the time bin with the highest contrast estimate as an estimation of the TTP latency. (B) HRF extracted from the peak voxel in the bilateral auditory cortex of patient 2 at day 2 (upper row) and day 8 (lower row). Plots represent mean contrast estimate across stimuli (x-axis) within each time bin (y-axis). From day 1 to day 8, TTP latency increased (from time bin 5 to time bin 6) and amplitude decreased slightly in both hemispheres.
Figure 3BOLD signal in controls and patient 6 performing language paradigm 2. (A) HRF extracted from the peak voxel in the bilateral auditory cortex of six healthy control subjects performing language paradigm 2. Plots represent the mean contrast estimate across subjects (y-axis) within each time bin (y-axis). The dark grey bar indicates the time bin with the highest contrast estimate as an estimation of the TTP latency. (B) HRF extracted from the peak voxel in the bilateral auditory cortex of patient 6 at day 1 (upper row) and day 9 (lower row). Plots represent mean contrast estimate across stimuli (x-axis) within each time bin (y-axis). From day 1 to day 9, TTP latency increased in both hemispheres (from time bin 6 to time bin 7) and amplitude decreased in the lesioned hemisphere.